MLYS: Mineralys Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 558.43
Enterprise Value ($M) 490.57
Book Value ($M) 290.10
Book Value / Share 5.83
Price / Book 1.92
NCAV ($M) 289.60
NCAV / Share 5.82
Price / NCAV 1.93

Profitability (mra)
Return on Invested Capital (ROIC) -0.41
Return on Assets (ROA) -0.41
Return on Equity (ROE) -0.42

Liquidity (mrq)
Quick Ratio 11.20
Current Ratio 11.20

Balance Sheet (mrq) ($M)
Current Assets 318.00
Assets 318.49
Liabilities 28.40
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -84.66
Net Income -71.90

Cash Flow Statement (mra) ($M)
Cash From Operations -81.17
Cash from Investing -160.47
Cash from Financing 203.25

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-15 13G TCG Crossover GP II, LLC 6.40
02-14 13G Adams Street Partners Llc 5.60
02-13 13G HBM Healthcare Investments (Cayman) Ltd. 5.50
02-13 13G Catalys Pacific Fund, LP 22.40
02-12 13D/A Samsara BioCapital, L.P. 10.30 12.61
02-12 13D/A Ra Capital Management, L.p. 9.99 55.59

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-09-09 11,060 51,888 21.32
2024-09-06 18,063 75,124 24.04
2024-09-05 16,928 71,099 23.81
2024-09-04 15,343 46,121 33.27

(click for more detail)

Similar Companies
MGNX – MacroGenics, Inc. MGTX – MeiraGTx Holdings plc
MIST – Milestone Pharmaceuticals Inc. MNMD – Mind Medicine (MindMed) Inc.
MRNA – Moderna, Inc.


Financial data and stock pages provided by
Fintel.io